XML 49 R38.htm IDEA: XBRL DOCUMENT v3.21.2
Reverse Recapitalization & Business Combinations - Narrative (Details)
3 Months Ended 9 Months Ended
Oct. 06, 2021
USD ($)
$ / shares
shares
Aug. 11, 2021
USD ($)
Jun. 29, 2021
shares
Mar. 12, 2021
shares
Feb. 26, 2021
USD ($)
day
$ / shares
shares
Oct. 31, 2021
USD ($)
Oct. 31, 2020
USD ($)
Oct. 31, 2021
USD ($)
Oct. 31, 2020
USD ($)
Jan. 31, 2021
USD ($)
Schedule Of Reverse Recapitalization [Line Items]                    
Recapitalization exchange ratio         0.9966          
Founder shares surrendered (in shares) | shares     9,000,000 9,000,000            
Number of trading days | day         10          
Number of consecutive trading days | day         20          
Earnout period (in years)         5 years          
Transaction costs expensed           $ 0 $ 0 $ (7,031,000) $ 0  
Goodwill, tax deductible amount           0   0    
Accumulated Amortization           1,519,000   1,519,000    
Deferred tax liabilities           $ 28,351,000   $ 28,351,000   $ 0
ViriCiti                    
Schedule Of Reverse Recapitalization [Line Items]                    
Cash consideration   $ 79,415,000                
Earnout contingent consideration   7,700,000                
Acquisition-related expenses   2,200,000                
Total purchase consideration   83,323,000                
Deferred tax liabilities   $ 3,400,000                
HTB                    
Schedule Of Reverse Recapitalization [Line Items]                    
Cash consideration $ 130,134,000                  
Acquisition-related expenses 2,600,000                  
Total purchase consideration 232,191,000                  
Common Stock consideration $ 102,057,000                  
Equity transferred (in shares) | shares 5,695,176                  
Equity transferred (in USD per share) | $ / shares $ 17.92                  
Shares held in escrow (in shares) | shares 885,692                  
Value of shares in escrow $ 15,900,000                  
Deferred tax liabilities $ 25,300,000                  
Risk-free interest rate | ViriCiti                    
Schedule Of Reverse Recapitalization [Line Items]                    
Measurement input   0.008                
Expected volatility | ViriCiti                    
Schedule Of Reverse Recapitalization [Line Items]                    
Measurement input   0.34                
Switchback                    
Schedule Of Reverse Recapitalization [Line Items]                    
Recapitalization exchange ratio         0.9966          
Recapitalization common stock value (in USD per share) | $ / shares         $ 10.00          
Legacy Chargepoint shares (in shares) | shares         217,021,368          
Shares reserved for potential future issuance upon exercise of stock options and warrants (in shares) | shares         68,896,516          
Shares reserved for potential future issuance of earnout shares (in shares) | shares         27,000,000          
Founder shares surrendered (in shares) | shares         984,706          
Additional earn back shares (in shares) | shares         900,000          
Earn Back price trigger (USD per share) | $ / shares         $ 12.00          
Number of trading days | day         10          
Number of consecutive trading days | day         20          
Earnout period (in years)         5 years          
Merger and PIPE financing shares (in shares) | shares         60,746,989          
Net cash contributions from merger         $ 511,600,000          
Cash - Switchback's trust and cash         286,600,000          
Repurchase of common stock         300,000          
Merger and PIPE financing         225,000,000          
Transaction costs expensed         36,500,000          
Transaction costs expensed         7,000,000          
Switchback | Additional Paid-In Capital                    
Schedule Of Reverse Recapitalization [Line Items]                    
Reduction to APIC         $ 29,500,000          
Switchback | Private Placement Warrants                    
Schedule Of Reverse Recapitalization [Line Items]                    
Debt converted into warrants (in shares) | shares         1,000,000          
Stock price of warrants (in dollars per share) | $ / shares         $ 1.50          
Converted instrument, principal amount         $ 1,500,000          
Switchback | Private Placement                    
Schedule Of Reverse Recapitalization [Line Items]                    
Number of shares sold (in shares) | shares         22,500,000          
Purchase price per share (USD per share) | $ / shares         $ 10.00          
Consideration received on sold shares         $ 225,000,000          
Switchback | Series H-1 Redeemable Convertible Preferred Stock                    
Schedule Of Reverse Recapitalization [Line Items]                    
Shares converted (in shares) | shares         22,427,306          
Recapitalization exchange ratio         1          
Common stock dividends (in shares) | shares         1,026,084          
Temporary equity, accrued dividends         $ 21,100,000          
Switchback | Series H, Series G, Series F, Series E, And Series D Redeemable Convertible Preferred Stock                    
Schedule Of Reverse Recapitalization [Line Items]                    
Shares converted (in shares) | shares         160,925,957          
Recapitalization exchange ratio         1          
Switchback | Series C Redeemable Convertible Preferred Stock                    
Schedule Of Reverse Recapitalization [Line Items]                    
Shares converted (in shares) | shares         45,376          
Recapitalization exchange ratio         73.4403          
Switchback | Series B Convertible Redeemable Preferred Stock                    
Schedule Of Reverse Recapitalization [Line Items]                    
Shares converted (in shares) | shares         130,590          
Recapitalization exchange ratio         42.9220          
Switchback | Series A Redeemable Convertible Preferred Stock                    
Schedule Of Reverse Recapitalization [Line Items]                    
Shares converted (in shares) | shares         29,126          
Recapitalization exchange ratio         48.2529